The latest health news
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox. It’s UFA week …
Read More
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox. Right to Try is the latest policy to …
Read More
On March 30, an FDA advisory panel voted 6 to 4 against recommending approval of what might be the most effective treatment to date for amyotrophic lateral sclerosis. The panel’s …
Read More
The confirmation of Robert Califf to lead the Food and Drug Administration is among the most consequential recent leadership appointments in Washington. In a polarized Senate, Califf’s past relationships with …
Read More
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox. Hello, D.C. Diagnosis …
Read More
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox. A top Trump …
Read More
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox. New legislative session …
Read More
Laser procedures promising “vaginal rejuvenation” are being promoted to women in advertisements online, in spa windows, and even in some doctors’ offices. If my patient group is any guide, women …
Read More
The FDA’s accelerated approval pathway has a potentially prominent champion — Robert Califf, the scientist President Biden has nominated to lead the FDA. This pathway opens the door to earlier approval …
Read More